论文部分内容阅读
目的探讨NT-ProBNP在治疗心血管疾病当中的意义,及在心源性和非心源性急性呼吸困难的鉴别诊断中的应用。方法回顾分析2008年5月至2011年10月到我院就诊的128例心血管疾病患者临床病例。结果 NT-ProBNP升高是患者疗效的独立标志物,能预防心衰及再梗的发生率,可对CHF患者进行危险性分层和预后。结论 NT-ProBNP的检测对心源性和非心源性急性呼吸困难的鉴别诊断具有明显的临床治疗效果,在急性冠脉综合征、慢性心力衰竭(CHF)患者的心功能、房颤及心内外相关手术管理中发挥着越来越重要的左右。
Objective To investigate the significance of NT-ProBNP in the treatment of cardiovascular diseases and its application in the differential diagnosis of cardiogenic and non-cardiac acute respiratory syndrome. Methods A retrospective analysis of clinical cases of 128 patients with cardiovascular diseases admitted to our hospital from May 2008 to October 2011 was conducted. Results The elevation of NT-ProBNP was an independent marker of the curative effect of patients. It could prevent the incidence of heart failure and re-infarction and could stratify and prognose the CHF patients. Conclusion The detection of NT-ProBNP has obvious clinical effect in the differential diagnosis of cardiogenic and noncardiogenic acute respiratory distress. In patients with acute coronary syndrome and chronic heart failure (CHF), the cardiac function, atrial fibrillation and heart Internal and external related surgical management plays an increasingly important role.